The Healthy Brain 9 (HB9): A new instrument to characterize subjective cognitive decline, and detect anosognosia in mild cognitive impairment

The Healthy Brain 9 (HB9): A new instrument to characterize subjective cognitive decline, and detect anosognosia in mild cognitive impairment

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	James E. Galvin, Katherine C. Almonte, Andrea Buehler, Yolene M. Caicedo, Conor B. Galvin, Willman Jimenez, Mahesh S. Joshi, Nicole Mendez, Mary Lou A. Riccio, Marcia I. Walker, Michael J. Kleiman
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12186938/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Healthy Brain 9 (HB9): A new instrument to characterize subjective cognitive decline, and detect anosognosia in mild cognitive impairment.
by: James E Galvin, et al.
Published: (2025-01-01)

Presence or absence of cognitive complaints in Parkinson’s disease: mood disorder or anosognosia?
by: Pollyanna Celso F. Castro, et al.

Excessive sleep is associated with worse cognition, cognitive decline, and dementia in mild cognitive impairment
by: Marieclaire Overton, et al.
Published: (2025-01-01)

Questionnaire «Opioid anosognosia» is a new tool for assessment anosognosia in opioid-dependent patients
by: R. D. Ilyuk, et al.
Published: (2025-03-01)

Cognitive cerebellum dominates motor cerebellum in functional decline of older adults with mild cognitive impairment.
by: Maria Devita, et al.
Published: (2025-01-01)

Sex differences in the relationship between olfactory and cognitive impairment among subjects with subjective cognitive decline and mild cognitive impairment
by: Qin Liu, et al.
Published: (2025-02-01)

The Role of Reality Monitoring in Anosognosia for Hemiplegia
by: Paul M. Jenkinson, et al.
Published: (2010-01-01)

Research on the application of functional near-infrared spectroscopy in differentiating subjective cognitive decline and mild cognitive impairment
by: Zheng Wang, et al.
Published: (2024-12-01)

Olfactory Identification as a Biomarker for Cognitive Impairment: Insights from Healthy Aging, Subjective Cognitive Decline, and Mild Cognitive Impairment
by: Jaime Bouhaben, et al.
Published: (2024-11-01)

Sequential patterning of dynamic brain states distinguish Parkinson’s disease patients with mild cognitive impairments
by: Aaron S. Kemp, et al.
Published: (2025-01-01)

Edaravone-Dexborneol slows down pathological progression and cognitive decline via inhibiting S100A9 in APPswe/PS1dE9 mice
by: Rui Mao, et al.
Published: (2025-06-01)

Prevalence of Subjective Cognitive Decline and Mild Cognitive Impairment in Rural Versus Urban Population: Insights from India
by: Dwaiti Roy, et al.
Published: (2025-01-01)

Exploring the neuromagnetic signatures of cognitive decline from mild cognitive impairment to Alzheimer's disease dementiaResearch in context
by: Sinead Gaubert, et al.
Published: (2025-04-01)

Association of plasma BDNF and MMP-9 levels with mild cognitive impairment: a matched case-control study
by: Tingyu Zhang, et al.
Published: (2024-12-01)

Anosognosia in patients with acute hemispheric ischemic stroke
by: V. N. Grigoryeva, et al.
Published: (2016-07-01)

A summary of the best evidence for story therapy to delay cognitive decline in the elder-ly with mild to moderate cognitive impairment
by: Chen SUN, et al.
Published: (2022-12-01)

Hippocampal Volume Loss as A Marker of Cognitive Decline in Dementia and Mild Cognitive Impairment: A Comprehensive Prospective Study
by: Shazia Bashir, et al.
Published: (2025-04-01)

Psychometric properties of the 9-item Posttraumatic Cognitions Inventory (PTCI-9) in an Iranian sample
by: Narges Barzgar, et al.
Published: (2024-12-01)

Is there a link between heart rate variability and cognitive decline? A cross-sectional study on patients with mild cognitive impairment and cognitively healthy controls
by: Bernhard Grässler, et al.
Published: (2023-01-01)

Anosognosia in dementia with Lewy bodies: a systematic review
by: Victor CALIL, et al.
Published: (2021-06-01)

Writing Errors and Anosognosia in Amyotrophic Lateral Sclerosis with Dementia
by: Hiroo Ichikawa, et al.
Published: (2008-01-01)

The LATTICE Study: Design of a pilot feasibility randomized controlled trial of lithium to delay cognitive decline in mild cognitive impairment
by: Ariel G. Gildengers, et al.
Published: (2025-04-01)

Event-related potential markers of subjective cognitive decline and mild cognitive impairment during a sustained visuo-attentive task
by: A.A. Vergani, et al.
Published: (2025-01-01)

The economic burden of subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia: excess costs and associated clinical and risk factors
by: Eva Gläser, et al.
Published: (2025-06-01)

Evaluating the safety and feasibility of remote ischemic conditioning for slowing cognitive decline in mild Alzheimer’s dementia
by: Xin Huang, et al.
Published: (2025-06-01)

Moderating role of triglycerides in the relationship between amyloid-β, hippocampal atrophy, and cognitive decline in mild cognitive impairment and early Alzheimer’s disease
by: Ji-Woo Seok, et al.
Published: (2025-08-01)

Distinct gut microbiota profiles and network properties in older Korean individuals with subjective cognitive decline, mild cognitive impairment, and Alzheimer’s disease
by: Sang Joon Son, et al.
Published: (2025-08-01)

Meditation for subjective cognitive decline, mild cognitive impairment and Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials
by: Jiaxin Shi, et al.
Published: (2025-05-01)

The two cut‐offs approach for plasma p‐tau217 in detecting Alzheimer's disease in subjective cognitive decline and mild cognitive impairment
by: Giulia Giacomucci, et al.
Published: (2025-04-01)

CORRELATION BETWEEN MRI-BASED BRAIN VOLUME CHANGES AND COGNITIVE DECLINE IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT: A PROSPECTIVE OBSERVATIONAL STUDY.
by: Karishma Khushalrao Surpam
Published: (2025-03-01)

The “Altitudinal Anton’s Syndrome”: Coexistence of Anosognosia, Blindsight and Left Inattention
by: A. Carota, et al.
Published: (2013-01-01)

S-9-PAHSA ameliorates cognitive decline in a type 2 diabetes mouse model by inhibiting oxidative stress and apoptosis via CAIII modulation
by: Xin-Ru Wang, et al.
Published: (2025-08-01)

Cardiovascular Prevention of Cognitive Decline
by: Jean-Jacques Monsuez, et al.
Published: (2011-01-01)

Near-moderate cognitive decline
by: N. N. Koberskaya, et al.
Published: (2020-04-01)

Cognitive Decline in Normal Ageing and Early Alzheimer’s Disease: A Continuous or Discontinuous Transition?
by: Pauline E. J. Spaan, et al.
Published: (2010-01-01)

Cognitive Performance Among Older Adults with Subjective Cognitive Decline
by: Ramón López-Higes, et al.
Published: (2025-03-01)

A retrospective study on blood microbiota as a marker for cognitive decline: implications for detecting Alzheimer’s disease and amnestic mild cognitive impairment in Republic of Korea
by: Youngchan Park, et al.
Published: (2025-04-01)

Assessing Social Interaction and Loneliness and Their Association With Frailty Among Older Adults With Subjective Cognitive Decline or Mild Cognitive Impairment: Ecological Momentary Assessment Approach
by: Bada Kang, et al.
Published: (2025-04-01)

An exploration of distinguishing subjective cognitive decline and mild cognitive impairment based on resting-state prefrontal functional connectivity assessed by functional near-infrared spectroscopy
by: Zhengping Pu, et al.
Published: (2025-01-01)

Cognitive profile in mild cognitive impairment with Lewy bodies
by: Shuai Liu, et al.
Published: (2023-08-01)